InsiderSignalSign in
← Insider buys

ITOS

Iteos Therapeutics, Inc.

No insider bought or sold Iteos Therapeutics, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo
Follow ITOS

ITOS over the last year

Prices for ITOS aren't in yet.

ITOS after insider buys

3 months after each buy, from the first price a copier could get.

−8.4%Average
−7.2 ptsVs S&P 500
1 of 3Higher

3 buys since 2021 with 3 months of prices.

Every filing

86 insider filings since 2021, newest first

ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$746K−1.0%Oct 5
ITOSSell

Ansbert Gadicke · 10% owner

$1.2M−1.0%Oct 5
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$581K−1.0%Sep 30
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$581K−1.0%Sep 30
ITOSSell

Ansbert Gadicke · 10% owner

$972K−1.0%Sep 30
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$1.5M−2.0%Sep 27
ITOSSell

Michel Detheux · CEO

$180K−6.0%Sep 27
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$1.5M−2.0%Sep 27
ITOSSell

Ansbert Gadicke · 10% owner

$2.5M−2.0%Sep 27
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$933K−1.0%Sep 23
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$933K−1.0%Sep 23
ITOSSell

Ansbert Gadicke · 10% owner

$1.6M−1.0%Sep 23
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$2.6M−3.0%Sep 20
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$2.6M−3.0%Sep 20
ITOSSell

Ansbert Gadicke · 10% owner

$4.3M−3.0%Sep 20
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$1.3M−1.0%Sep 16
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$1.3M−1.0%Sep 16
ITOSSell

Ansbert Gadicke · 10% owner

$2.1M−1.0%Sep 16
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$1.6M−2.0%Sep 13
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$1.6M−2.0%Sep 13
ITOSSell

Ansbert Gadicke · 10% owner

$2.7M−2.0%Sep 13
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$1.2M−1.0%Sep 8
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$1.2M−1.0%Sep 8
ITOSSell

Ansbert Gadicke · 10% owner

$2.1M−1.0%Sep 8
ITOSSell

Michel Detheux · CEO

$581K−16.0%Sep 3
ITOSSell

Michel Detheux · CEO

$412K−10.0%Aug 31
ITOSSell

Michel Detheux · CEO

$241K−6.0%Aug 25
ITOSBuy

Matthew Gall · CFO

$130KJun 16
ITOSSell

Michel Detheux · CEO

$827K−16.0%Jun 16
ITOSSell

Yvonne Mcgrath · VP, Research, Development

$159K−100.0%Jun 10
ITOSSell

Yvonne Mcgrath · VP, Research, Development

$160K−100.0%Jun 3
ITOSSell

Yvonne Mcgrath · VP, Research, Development

$174K−100.0%Jun 3
ITOSSell

Yvonne Mcgrath · VP, Research, Development

$196K−100.0%May 19
ITOSSell

Mpm Bioventures 2014, L.P. · 10% owner

$777K−1.0%Apr 9
ITOSSell

Ansbert Gadicke · 10% owner

$1.3M−1.0%Apr 9
ITOSSell

Mpm Bioventures 2018, L.P. · 10% owner

$777K−1.0%Apr 9
Newer filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.